[Pharmacotherapy of the alcohol withdrawal syndrome (author's transl)].
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines; D000431:Ethanol / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008278:Magnesium Sulfate / Q000627:therapeutic use; D010640:Phenothiazines; D011433:Propranolol / Q000627:therapeutic use; D011604:Psychoses, Alcoholic / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D010640:Phenothiazines; D001569:Benzodiazepines; D000431:Ethanol; D008278:Magnesium Sulfate; D011433:Propranolol; D006220:Haloperidol
Farmacoterapía del síndrome de privación alcohólica.